Vitrolife AB
XMUN:VTFN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Vitrolife AB (VTFN) under the Base Case is 10.29 EUR per share.
Compared with the current market price of 10.6 EUR, the stock appears
Overvalued by 3% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Vitrolife AB Does
Vitrolife AB makes products and services used in fertility treatment and assisted reproduction. Its main customers are IVF clinics and other fertility specialists, who use the company’s lab equipment, culture media, needles, dishware, and related consumables to handle eggs, sperm, embryos, and genetic testing during treatment. In plain terms, Vitrolife sells the tools and materials clinics need to help patients go through IVF procedures.
- Headquarters
- Sweden SE
- Employees
- 1 126
- IPO date
- Jun 26, 2001
Balance Sheet
Recent Events
Latest Earnings Call
Vitrolife emphasized scaling technology adoption and innovation while directing resources toward profitable markets, against uneven regional IVF demand and persistent softness in China.
What management delivered: 1 worse than forecast
Open the earnings call- EPS
- kr0.94
- Expected
- kr0.93
- Surprise
- +1.1%
- Stock, day of the call
- +5.0%
Past 12 months
Continue VTFN Research
Decided on Vitrolife? Get an email when VTFN reaches the price you’d buy at. Free with an account.
Other Vitrolife listings
What is the Intrinsic Value of one VTFN stock?
The intrinsic value for
Vitrolife AB (VTFN) under the Base Case is 10.29 EUR.
Is VTFN stock undervalued or overvalued?
Compared with the current market price of 10.6 EUR, the stock appears Overvalued by 3% .